Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure

NCT05538819 is registered in ClinicalTrials.gov with Dao Wen Wang as lead sponsor.

NCT NCT05538819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05538819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure
Lead sponsor
Dao Wen Wang
Phase
Observational
Overall status
Completed
Start date
June 1, 2017
Completion date
July 1, 2022
Enrollment
1,018 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular mortality, chronic heart failure, cohort study, type 2 diabetes